MCID: HYP057
MIFTS: 40

Hypervitaminosis D

Categories: Metabolic diseases

Aliases & Classifications for Hypervitaminosis D

MalaCards integrated aliases for Hypervitaminosis D:

Name: Hypervitaminosis D 12 76 15 73

Classifications:



External Ids:

Disease Ontology 12 DOID:9971
ICD10 33 E67.3
ICD9CM 35 278.4
SNOMED-CT 68 27712000
UMLS 73 C1442839

Summaries for Hypervitaminosis D

MalaCards based summary : Hypervitaminosis D is related to bone resorption disease and calcinosis. An important gene associated with Hypervitaminosis D is PTH (Parathyroid Hormone), and among its related pathways/superpathways are Negative regulation of FGFR1 signaling and Signaling by FGFR2. The drugs Ergocalciferol and Vitamin D3 have been mentioned in the context of this disorder. Affiliated tissues include bone, kidney and smooth muscle, and related phenotypes are cardiovascular system and cellular

Wikipedia : 76 Hypervitaminosis D is a state of vitamin D toxicity. The normal range for blood concentration is 30.0... more...

Related Diseases for Hypervitaminosis D

Diseases in the Hypervitaminosis a family:

Hypervitaminosis D

Diseases related to Hypervitaminosis D via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 58)
# Related Disease Score Top Affiliating Genes
1 bone resorption disease 29.9 PTH VDR
2 calcinosis 29.8 FGF23 GALNT3 KL
3 rickets 29.5 CYP27B1 FGF23 PTH VDR
4 hyperparathyroidism 29.3 CYP27B1 FGF23 PTH VDR
5 osteoporosis 29.0 CYP27B1 FGF23 KL PTH VDR
6 arterial calcification of infancy 11.3
7 oncogenic osteomalacia 10.1 FGF23 PTH
8 impaired renal function disease 10.1 FGF23 PTH
9 pulmonary alveolar microlithiasis 10.1 FGF23 PTH
10 hypercalcemia, infantile, 1 10.1 PTH VDR
11 metaphyseal chondrodysplasia, jansen type 10.1 FGF23 PTH
12 tracheal calcification 10.1 FGF23 KL
13 diabetes insipidus, nephrogenic, autosomal 10.1
14 arteriosclerosis 10.1
15 diabetes insipidus 10.1
16 hypophosphatemia 10.0 FGF23 PTH
17 idiopathic hypercalciuria 10.0 TRPV5 VDR
18 autosomal recessive hypophosphatemic rickets 10.0 FGF23 GALNT3
19 hypophosphatemic rickets, autosomal dominant 10.0 FGF23 GALNT3
20 parathyroid adenoma 10.0 PTH VDR
21 lacrimoauriculodentodigital syndrome 9.9 FGF23 GALNT3
22 hypoparathyroidism 9.9 FGF23 PTH
23 calciphylaxis 9.9 FGF23 PTH VDR
24 hypophosphatemic rickets, x-linked dominant 9.9 FGF23 KL PTH
25 parathyroid gland disease 9.9 FGF23 PTH VDR
26 renal osteodystrophy 9.9 FGF23 PTH VDR
27 hypocalcemia, autosomal dominant 1 9.9 FGF23 PTH VDR
28 bone remodeling disease 9.9 FGF23 PTH VDR
29 osteomalacia 9.9 FGF23 PTH VDR
30 urinary system disease 9.9 FGF23 KL PTH
31 spondylosis 9.9 KL PTH VDR
32 vitamin d-dependent rickets, type 2a 9.9 CYP27B1 VDR
33 primary hyperparathyroidism 9.9 FGF23 PTH VDR
34 bone disease 9.9 FGF23 PTH VDR
35 alagille syndrome 1 9.9
36 rheumatoid arthritis 9.9
37 cystic fibrosis 9.9
38 hypervitaminosis a 9.9
39 intracranial hypertension, idiopathic 9.9
40 aging 9.9
41 arthritis 9.9
42 mannosidosis 9.9
43 fanconi syndrome 9.9
44 pulmonary tuberculosis 9.9
45 pneumonia 9.9
46 familial tumoral calcinosis 9.8 FGF23 GALNT3 KL
47 uremia 9.8 PTH VDR
48 tumoral calcinosis, hyperphosphatemic, familial, 1 9.8 FGF23 GALNT3 KL
49 hyperostosis 9.8 FGF23 GALNT3 KL
50 kidney disease 9.8 FGF23 PTH VDR

Graphical network of the top 20 diseases related to Hypervitaminosis D:



Diseases related to Hypervitaminosis D

Symptoms & Phenotypes for Hypervitaminosis D

MGI Mouse Phenotypes related to Hypervitaminosis D:

46 (show all 14)
# Description MGI Source Accession Score Top Affiliating Genes
1 cardiovascular system MP:0005385 10.01 CYP27B1 FGF23 GALNT3 KL PTH VDR
2 cellular MP:0005384 10 CYP27B1 GALNT3 KL PTH TRPV5 VDR
3 growth/size/body region MP:0005378 10 CYP27B1 FGF23 GALNT3 KL PTH TRPV5
4 hematopoietic system MP:0005397 9.98 CYP27B1 FGF23 GALNT3 KL PTH TRPV5
5 endocrine/exocrine gland MP:0005379 9.95 CYP27B1 FGF23 GALNT3 KL PTH VDR
6 homeostasis/metabolism MP:0005376 9.95 CYP27B1 FGF23 GALNT3 KL PTH TRPV5
7 craniofacial MP:0005382 9.91 CYP27B1 GALNT3 KL PTH VDR
8 immune system MP:0005387 9.91 CYP27B1 FGF23 GALNT3 KL PTH TRPV5
9 digestive/alimentary MP:0005381 9.89 FGF23 GALNT3 KL TRPV5 VDR
10 limbs/digits/tail MP:0005371 9.73 CYP27B1 FGF23 GALNT3 KL PTH VDR
11 integument MP:0010771 9.72 CYP27B1 FGF23 GALNT3 KL VDR
12 renal/urinary system MP:0005367 9.63 CYP27B1 FGF23 GALNT3 KL TRPV5 VDR
13 reproductive system MP:0005389 9.35 CYP27B1 FGF23 GALNT3 KL VDR
14 skeleton MP:0005390 9.17 CYP27B1 FGF23 GALNT3 KL PTH TRPV5

Drugs & Therapeutics for Hypervitaminosis D

Drugs for Hypervitaminosis D (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 17)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Ergocalciferol Approved, Nutraceutical Phase 4,Phase 2,Phase 1,Not Applicable 50-14-6 5280793
2
Vitamin D3 Approved, Nutraceutical Phase 4,Phase 2,Phase 1,Not Applicable 67-97-0 5280795 6221
3
Vitamin D Approved, Nutraceutical, Vet_approved Phase 4,Phase 2,Phase 1,Not Applicable 1406-16-2
4 Trace Elements Phase 4,Phase 2,Phase 1,Not Applicable
5 Hydroxycholecalciferols Phase 4
6 Calcifediol Phase 4 19356-17-3
7 Ergocalciferols Phase 4,Phase 2,Phase 1,Not Applicable
8 Vitamins Phase 4,Phase 2,Phase 1,Not Applicable
9 Micronutrients Phase 4,Phase 2,Phase 1,Not Applicable
10 Bone Density Conservation Agents Phase 4,Phase 2,Phase 1,Not Applicable
11 Calciferol Phase 4,Phase 2,Phase 1,Not Applicable
12 Vitamin D2 Phase 4,Phase 2,Phase 1,Not Applicable
13 Pharmaceutical Solutions Phase 2,Not Applicable
14 Hepcidins Phase 2
15 Anti-Infective Agents Phase 2
16 Olive Not Applicable
17 Calcium, Dietary Not Applicable

Interventional clinical trials:

(show all 11)
# Name Status NCT ID Phase Drugs
1 The Effect of Supplementation With Two Different Doses of Vitamin D on Bone Mineral Density, Vitamin D Levels and Hand Grip Strength in Children With Diabetes Mellitus Type 1 Completed NCT01277913 Phase 4 Vitamin D3;Vitamin D3
2 A Randomized Phase IV Control Trial of Single High Dose Oral Vitamin D3 in Pediatric Patients Undergoing HSCT Enrolling by invitation NCT03176849 Phase 4
3 Rapid Normalization of Vitamin D Deficiency in PICU Not yet recruiting NCT03742505 Phase 3 Cholecalciferol
4 Prevention of Vitamin D Deficiency Following Pediatric CHD Surgery: a Phase II Dose Evaluation Randomized Controlled Trial Comparing Usual Care With a High Dose Pre-operative Supplementation Regimen Based on the Institute of Medicine Daily Upper Tolerable Intake Level Completed NCT01838447 Phase 2
5 Vitamin D as a Modifier of Serum Hepcidin in Children With Chronic Kidney Disease Completed NCT01532349 Phase 2 Cholecalciferol
6 Vitamin D and Severe Asthma Exacerbations Completed NCT01921894 Phase 1
7 Pilot Trial to Evaluate the Effect of Vitamin D on Melanocyte Biomarkers Completed NCT01477463 Not Applicable Vitamin D3;placebo and vitamin D
8 Efficacy of Vitamin D Therapy on Glucose Homeostasis in Obese Adolescents Completed NCT02414529 Not Applicable Vitamin D2;Placebo
9 Change in Free 25(OH)D After High Dose in Vitamin D Deficient Postmenopausal Women Active, not recruiting NCT02553044 Not Applicable
10 Randomized Study of Two Vitamin D Dosing Strategies in Children With Chronic Kidney Disease Active, not recruiting NCT01909115 Not Applicable
11 Dose-dependent Effects of Vitamin D on Bone Health Active, not recruiting NCT01900860 Not Applicable

Search NIH Clinical Center for Hypervitaminosis D

Genetic Tests for Hypervitaminosis D

Anatomical Context for Hypervitaminosis D

MalaCards organs/tissues related to Hypervitaminosis D:

41
Bone, Kidney, Smooth Muscle, Placenta

Publications for Hypervitaminosis D

Articles related to Hypervitaminosis D:

(show top 50) (show all 121)
# Title Authors Year
1
SUSPECTED HYPERVITAMINOSIS D IN RED-RUMPED AGOUTI ( DASYPROCTA LEPORINA) RECEIVING A COMMERCIAL RODENT DIET. ( 29517453 )
2018
2
Risks of the 'Sunshine pill' - a case of hypervitaminosis D. ( 30072556 )
2018
3
Hypervitaminosis D Associated With Tanning Bed Use: A Case Report. ( 28114469 )
2017
4
Can adverse effects of excessive vitamin D supplementation occur without developing hypervitaminosis D? ( 28734988 )
2017
5
Vitamin D deficiency: It is time for reality check of the epidemiology. Re. "The increasing problem of subclinical and overt hypervitaminosis D in India: An institutional experience and review." ( 28652074 )
2017
6
The increasing problem of subclinical and overt hypervitaminosis D in India: An institutional experience and review. ( 28063517 )
2017
7
Prevalence of hypercalcemia related to hypervitaminosis D in clinical practice. ( 26995293 )
2016
8
Hypervitaminosis D with Dyslipidemia: An Unusual Scenario. ( 26897163 )
2016
9
Clinical investigation into feed-related hypervitaminosis D in a captive flock of budgerigars (Melopsittacus undulatus): morbidity, mortalities, and pathologic lesions. ( 25831571 )
2015
10
Reversible vascular calcifications associated with hypervitaminosis D. ( 26318020 )
2015
11
Acute Hypercalcaemia and Hypervitaminosis D in an Infant with Extra Pulmonary Tuberculosis. ( 26557587 )
2015
12
Hypervitaminosis-D, an uncommon reality! ( 25906526 )
2014
13
Hypervitaminosis D and Metastatic Calcification in a Colony of Inbred Strain 13 Guinea Pigs, Cavia porcellus. ( 25281651 )
2014
14
Tanning beds and hypervitaminosis D: a case report. ( 24887628 )
2014
15
Iatrogenic hypervitaminosis D as an unusual cause of persistent vomiting: a case report. ( 24571630 )
2014
16
Maternal hypervitaminosis D reduces fetal bone mass and mineral acquisition and leads to neonatal lethality. ( 23895994 )
2013
17
Early life permethrin exposure leads to hypervitaminosis D, nitric oxide and catecholamines impairment. ( 25149241 )
2013
18
Hypervitaminosis D in guinea pigs with I+-mannosidosis. ( 23582422 )
2013
19
Treatment of nephrogenic diabetes insipidus due to hypervitaminosis D. ( 23756934 )
2013
20
Hypervitaminosis D causing nephrogenic diabetes insipidus in a 5-month-old infant. ( 23396467 )
2013
21
"Excess gooD can be Dangerous". A case series of iatrogenic symptomatic hypercalcemia due to hypervitaminosis D. ( 23087723 )
2012
22
Serum levels of 3-epi-25-OH-D3 during hypervitaminosis D in clinical practice. ( 23038681 )
2012
23
Hypervitaminosis D: case report of pediatric osteoporosis secondary to cystic fibrosis. ( 22461833 )
2011
24
Hypervitaminosis D associated with a vitamin D dispensing error. ( 21917555 )
2011
25
Neurofibromatosis, pathological fracture and hypervitaminosis-D. ( 21048240 )
2010
26
Pseudotumor cerebri due to hypervitaminosis A or hypervitaminosis D or both in Alagille syndrome. ( 19619235 )
2010
27
Hypercalcemia due to hypervitaminosis D: report of seven patients. ( 19339514 )
2009
28
Ventricular-arterial coupling in a rat model of reduced arterial compliance provoked by hypervitaminosis D and nicotine. ( 16699077 )
2006
29
Hypervitaminosis D and premature aging: lessons learned from Fgf23 and Klotho mutant mice. ( 16731043 )
2006
30
Hypervitaminosis D mediates compensatory Ca2+ hyperabsorption in TRPV5 knockout mice. ( 16148038 )
2005
31
Risk of hypervitaminosis D from prolonged feeding of high vitamin D premature infant formula. ( 15310310 )
2004
32
1,25-dihydroxyvitamin D3 receptor is upregulated in aortic smooth muscle cells during hypervitaminosis D. ( 12002522 )
2002
33
Hypercalcemia and hypervitaminosis D in two lambs. ( 10754674 )
2000
34
Effects of plant-induced hypervitaminosis D on cutaneous structure, cell differentiation and cell proliferation in cattle. ( 10887751 )
2000
35
Hypervitaminosis D: Report on three patients. ( 17341976 )
1998
36
Dental changes in hypervitaminosis D. ( 9574950 )
1998
37
[Hypervitaminosis D in institutionalized elderly in Buenos Aires]. ( 9435366 )
1997
38
An outbreak of hypervitaminosis D associated with the overfortification of milk from a home-delivery dairy. ( 7733425 )
1995
39
Hypervitaminosis D after prolonged feeding with a premature formula. ( 8233752 )
1993
40
Hypervitaminosis D associated with drinking milk. ( 1313547 )
1992
41
Up-regulation of the intestinal 1,25-dihydroxyvitamin D receptor during hypervitaminosis D: a comparison between vitamin D2 and vitamin D3. ( 2163637 )
1990
42
Effect of ethane-I-hydroxy-I, I-diphosphonate on arterial calcinosis induced by hypervitaminosis D: a morphologic investigation. ( 2109995 )
1990
43
Ultrastructural study of hypervitaminosis D induced arterial calcification in Wistar rats. ( 3207390 )
1988
44
Dietary magnesium effect on swine coronary atherosclerosis induced by hypervitaminosis D. ( 2820185 )
1987
45
Severe depressive illness in the context of hypervitaminosis D. ( 3664111 )
1987
46
The osteodystrophy of hypervitaminosis D: a metabolic study. ( 3498181 )
1986
47
Hypervitaminosis D in the chick embryo: comparative study on the activity of various vitamin D3 metabolites. ( 6091851 )
1984
48
Effect of alkali on metastatic calcification produced by hypervitaminosis D. ( 6098694 )
1984
49
The role of 25-hydroxy-vitamin D3 in the induction of atherosclerosis in swine and rabbit by hypervitaminosis D. ( 6837312 )
1983
50
Direct measurement of bone resorption and calcium conservation during vitamin D deficiency or hypervitaminosis D. ( 6246506 )
1980

Variations for Hypervitaminosis D

Expression for Hypervitaminosis D

Search GEO for disease gene expression data for Hypervitaminosis D.

Pathways for Hypervitaminosis D

Pathways related to Hypervitaminosis D according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1
Show member pathways
12.16 FGF23 GALNT3 KL
2
Show member pathways
11.83 FGF23 GALNT3 KL
3
Show member pathways
11.24 FGF23 GALNT3
4 11.13 CYP27B1 FGF23 KL PTH TRPV5 VDR
5 11.1 KL TRPV5 VDR
6 11.02 PTH VDR
7 10.99 CYP27B1 PTH VDR
8 10.95 CYP27B1 VDR
9 10.47 FGF23 PTH
10 10.13 CYP27B1 PTH VDR

GO Terms for Hypervitaminosis D

Biological processes related to Hypervitaminosis D according to GeneCards Suite gene sharing:

(show all 17)
# Name GO ID Score Top Affiliating Genes
1 regulation of signaling receptor activity GO:0010469 9.73 FGF23 KL PTH
2 fibroblast growth factor receptor signaling pathway GO:0008543 9.58 FGF23 GALNT3 KL
3 cellular calcium ion homeostasis GO:0006874 9.57 PTH VDR
4 phosphatidylinositol-3-phosphate biosynthetic process GO:0036092 9.55 FGF23 KL
5 bone mineralization GO:0030282 9.54 CYP27B1 PTH
6 positive regulation of bone mineralization GO:0030501 9.52 KL PTH
7 decidualization GO:0046697 9.51 CYP27B1 VDR
8 regulation of bone mineralization GO:0030500 9.49 CYP27B1 FGF23
9 response to vitamin D GO:0033280 9.48 CYP27B1 PTH
10 positive regulation of keratinocyte differentiation GO:0045618 9.46 CYP27B1 VDR
11 calcium ion transport GO:0006816 9.46 CYP27B1 PTH TRPV5 VDR
12 phosphate ion homeostasis GO:0055062 9.43 FGF23 PTH
13 calcium ion homeostasis GO:0055074 9.43 CYP27B1 KL TRPV5
14 positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway GO:0090080 9.37 FGF23 KL
15 vitamin D catabolic process GO:0042369 9.32 CYP27B1 FGF23
16 vitamin D metabolic process GO:0042359 9.13 CYP27B1 FGF23 VDR
17 positive regulation of vitamin D 24-hydroxylase activity GO:0010980 8.8 CYP27B1 FGF23 VDR

Molecular functions related to Hypervitaminosis D according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 phosphatidylinositol-4,5-bisphosphate 3-kinase activity GO:0046934 9.26 FGF23 KL
2 1-phosphatidylinositol-3-kinase activity GO:0016303 9.16 FGF23 KL
3 fibroblast growth factor receptor binding GO:0005104 8.96 FGF23 KL
4 vitamin D binding GO:0005499 8.62 KL VDR

Sources for Hypervitaminosis D

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
Content
Loading form....